Behrman Stephen W, Mulloy Matthew
Department of Surgery, University of Tennessee, Memphis, Tennessee 38163, USA.
Am Surg. 2006 Apr;72(4):297-302.
Total pancreatectomy (TP) for chronic pancreatitis (CP) has not gained widespread acceptance because of concerns regarding technical complexity, diabetic complications, and uncertainty with respect to long-term pain relief. Records of patients having TP from 1997 to 2005 were reviewed. Patient presentation, etiology of disease, and the indication for TP were examined. Operative results were analyzed. Long-term results were critically assessed, including narcotic usage and the need for re-admission. Postoperative quality of life (QOL) was assessed by the SF-36 health survey. During the study period, 7 patients with CP had TP, and 28 had other operations. The etiology of CP was alcohol in four and hereditary pancreatitis in three. The indication for surgery was pain and weight loss. Preoperatively, all patients used narcotics chronically and two had insulin-dependent diabetes. Four had TP after failed previous surgical procedures. Endoscopic retrograde cholangiopancreatography and computed tomography demonstrated small ducts and atrophic calcified glands. The mean length of the operation was 468 minutes, and only two patients required transfusion. There were no biliary anastomotic complications. The mean length of stay was 14 days. Major morbidity was limited to a single patient with a leak from the gastrojejunal anastomosis. Thirty-day mortality was zero, with one late death unrelated to the surgical procedure or diabetes. The mean length of follow-up was 46 months. All patients remained alcohol and narcotic free. No patient was readmitted with a diabetic complication. When compared with the general population, QOL scores were diminished but reasonable. We conclude that TP is indicated in hereditary pancreatitis and in those with an atrophic, calcified pancreas with small duct disease; that TP is technically arduous but can be completed with very low morbidity and mortality; and that on long-term follow-up, pain relief and abstinence from alcohol and narcotics was excellent with an acceptable QOL.
由于对技术复杂性、糖尿病并发症以及长期疼痛缓解的不确定性存在担忧,全胰切除术(TP)治疗慢性胰腺炎(CP)尚未得到广泛认可。回顾了1997年至2005年接受TP治疗的患者记录。检查了患者的临床表现、疾病病因以及TP的适应证。分析了手术结果。对长期结果进行了严格评估,包括麻醉药物使用情况和再次入院的必要性。通过SF-36健康调查评估术后生活质量(QOL)。在研究期间,7例CP患者接受了TP治疗,28例接受了其他手术。CP的病因在4例中为酒精性,3例为遗传性胰腺炎。手术适应证为疼痛和体重减轻。术前,所有患者长期使用麻醉药物,2例患有胰岛素依赖型糖尿病。4例患者在先前手术失败后接受了TP治疗。内镜逆行胰胆管造影和计算机断层扫描显示胰管细小且腺体萎缩钙化。手术平均时长为468分钟,仅2例患者需要输血。未发生胆肠吻合并发症。平均住院时长为14天。主要并发症仅限于1例胃空肠吻合口漏患者。30天死亡率为零,1例晚期死亡与手术或糖尿病无关。平均随访时长为46个月。所有患者均不再饮酒和使用麻醉药物。无患者因糖尿病并发症再次入院。与普通人群相比,QOL评分有所降低,但仍属合理。我们得出结论,TP适用于遗传性胰腺炎以及胰腺萎缩、钙化且伴有胰管细小病变的患者;TP技术难度大,但可以在极低的发病率和死亡率下完成;长期随访显示,疼痛缓解以及戒酒和停用麻醉药物效果良好,QOL可接受。